BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17257088)

  • 1. Improving the treatment of hepatitis C infection in the UK.
    Cooke GS; Main J
    Expert Opin Pharmacother; 2007 Feb; 8(2):183-91. PubMed ID: 17257088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C virus infection in children.
    Mohan N; González-Peralta RP; Fujisawa T; Chang MH; Heller S; Jara P; Kelly D; Mieli-Vergani G; Shah U; Murray KF
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):123-31. PubMed ID: 20038846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C in children is a mild and curable liver disease.
    Di Marco V
    Dig Liver Dis; 2011 Apr; 43(4):266-7. PubMed ID: 21353653
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon-alpha.
    Antonelli G; Riva E; Maggi F; Vatteroni ML; Simeoni E
    J Infect Dis; 1999 Oct; 180(4):1411-2. PubMed ID: 10479188
    [No Abstract]   [Full Text] [Related]  

  • 5. HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy.
    Paolucci S; Premoli M; Ludovisi S; Mondelli MU; Baldanti F
    Antivir Ther; 2017; 22(4):365-368. PubMed ID: 28085002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFFECTIVE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTIONS WITH DIRECT ACTING ANTIVIRALS IN PRISONS SYSTEM.
    Vashakidze E; Imnadze T; Mikadze I
    Georgian Med News; 2018 Jan; (274):112-116. PubMed ID: 29461238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.
    Torres HA; Chong PP; De Lima M; Friedman MS; Giralt S; Hammond SP; Kiel PJ; Masur H; McDonald GB; Wingard JR; Gambarin-Gelwan M
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1870-82. PubMed ID: 26256943
    [No Abstract]   [Full Text] [Related]  

  • 9. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
    Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
    J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha therapy exerts selective pressure on hepatitis C virus quasispecies equilibrium.
    Mizokami M; Ohno T; Ohba K; Davis GL; Suzuki K; Orito E; Lau JY
    Antivir Ther; 1999; 4(1):15-9. PubMed ID: 10682124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
    Yang J; Rao HY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):175-178. PubMed ID: 29804389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Evolving Treatments of Genotype 1 Hepatitis C Virus.
    Alqahtani S; Sulkowski M
    Gastroenterol Clin North Am; 2015 Dec; 44(4):825-43. PubMed ID: 26600222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus: A European Perspective.
    Dultz G; Zeuzem S
    Gastroenterol Clin North Am; 2015 Dec; 44(4):807-24. PubMed ID: 26600221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparing the patient for success: treat or wait?
    Buti M; Esteban R
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S332-6. PubMed ID: 24091112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we nearing the end in the fight against hepatitis C?
    Chua JV; Kottilil S
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):499-500. PubMed ID: 28335650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of hepatitis C].
    Moradpour D; Blum HE
    Praxis (Bern 1994); 2002 May; 91(22):977-82. PubMed ID: 12094432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response.
    Floreani A; Cazzagon N; Boemo DG; Baldovin T; Baldo V; Egoue J; Antoniazzi S; Minola E
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):997-1003. PubMed ID: 21915057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation.
    Gurusamy KS; Tsochatzis E; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006573. PubMed ID: 21154370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic hepatitis C].
    Rókusz L
    Orv Hetil; 2004 Aug; 145(32):1649-53. PubMed ID: 15384863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2010 Feb; 25(2):221-3. PubMed ID: 20136983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.